Literature DB >> 15597462

[Therapeutic adherence and schizophrenia: the interest of the validation of the French translation of Medication Adherence Rating Scale (MARS)].

D Misdrahi, H Verdoux, P-M Llorca, F-J Baylé.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15597462

Source DB:  PubMed          Journal:  Encephale        ISSN： 0013-7006            Impact factor:   1.291


× No keyword cloud information.
  11 in total

1.  Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort.

Authors:  G Fond; O Godin; L Boyer; F Berna; M Andrianarisoa; N Coulon; L Brunel; E Bulzacka; B Aouizerate; D Capdevielle; I Chereau; T D'Amato; C Dubertret; J Dubreucq; C Faget; S Leignier; C Lançon; J Mallet; D Misdrahi; C Passerieux; R Rey; A Schandrin; M Urbach; P Vidailhet; P M Llorca; F Schürhoff; M Leboyer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-05-28       Impact factor: 5.270

2.  Characteristics associated with self-reported medication adherence in persons with psychosis referred to psychosocial rehabilitation centers.

Authors:  Hélène Verdoux; Clélia Quiles; Laura Bon; Isabelle Chéreau-Boudet; Julien Dubreucq; Emilie Legros-Lafarge; Nathalie Guillard-Bouhet; Catherine Massoubre; Julien Plasse; Nicolas Franck
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-11-10       Impact factor: 5.270

3.  Validation of the Medication Adherence Rating Scale in homeless patients with schizophrenia: Results from the French Housing First experience.

Authors:  K Zemmour; A Tinland; M Boucekine; V Girard; S Loubière; N Resseguier; G Fond; P Auquier; L Boyer
Journal:  Sci Rep       Date:  2016-08-18       Impact factor: 4.379

4.  The role of the affective temperament in the treatment adherence in psychiatry.

Authors:  Lilia Bahrini; Rahma Damak; Mejda Cheour
Journal:  Pan Afr Med J       Date:  2016-09-02

5.  Significant Need for a French Network of Expert Centers Enabling a Better Characterization and Management of Treatment-Resistant Depression (Fondation FondaMental).

Authors:  Antoine Yrondi; Djamila Bennabi; Emmanuel Haffen; Marion Garnier; Frank Bellivier; Thierry Bourgerol; Vincent Camus; Thierry D'Amato; Olivier Doumy; Frédéric Haesebaert; Jérôme Holtzmann; Christophe Lançon; Philippe Vignaud; Fanny Moliere; Isabel Nieto; Raphaëlle Marie Richieri; Philippe Domenech; Corentin Rabu; Luc Mallet; Liova Yon; Laurent Schmitt; Florian Stephan; Guillaume Vaiva; Michel Walter; Pierre-Michel Llorca; Philippe Courtet; Marion Leboyer; Wissam El-Hage; Bruno Aouizerate
Journal:  Front Psychiatry       Date:  2017-11-24       Impact factor: 4.157

6.  Efficacy of shared decision-making on treatment adherence of patients with bipolar disorder: a cluster randomized trial (ShareD-BD).

Authors:  L Samalin; M Honciuc; L Boyer; I de Chazeron; O Blanc; M Abbar; P M Llorca
Journal:  BMC Psychiatry       Date:  2018-04-13       Impact factor: 3.630

7.  Impact of a paediatric-adult care transition programme on the health status of patients with sickle cell disease: study protocol for a randomised controlled trial (the DREPADO trial).

Authors:  Delphine Hoegy; Nathalie Bleyzac; Alexandra Gauthier-Vasserot; Giovanna Cannas; Angélique Denis; Arnaud Hot; Yves Bertrand; Pauline Occelli; Sandrine Touzet; Claude Dussart; Audrey Janoly-Dumenil
Journal:  Trials       Date:  2020-02-10       Impact factor: 2.279

8.  Pharmacological treatment profiles in the FACE-BD cohort: Treatment description and complete data for bipolar subtypes.

Authors:  Sébastien Brodeur; Hugo Terrisse; Arnaud Pouchon; Ophelia Godin; Bruno Aouizerate; Valerie Aubin; Frank Bellivier; Raoul Belzeaux; Thierry Bougerol; Philippe Courtet; Caroline Dubertret; Sebastien Gard; Emmanuel Haffen; Chantal Henry; Marion Leboyer; Emilie Olié; Paul Roux; Ludovic Samalin; Raymund Schwan; Bruno Etain; Jean-Luc Bosson; Mircea Polosan
Journal:  Data Brief       Date:  2021-03-25

9.  Examining transcranial random noise stimulation as an add-on treatment for persistent symptoms in schizophrenia (STIM'Zo): a study protocol for a multicentre, double-blind, randomized sham-controlled clinical trial.

Authors:  Jerome Brunelin; Marine Mondino; Julie Haesebaert; Jerome Attal; Michel Benoit; Marie Chupin; Sonia Dollfus; Wissam El-Hage; Filipe Galvao; Renaud Jardri; Pierre Michel Llorca; Laurent Magaud; Marion Plaze; Anne Marie Schott-Pethelaz; Marie-Françoise Suaud-Chagny; David Szekely; Eric Fakra; Emmanuel Poulet
Journal:  Trials       Date:  2021-12-28       Impact factor: 2.279

10.  Immune Signatures of Treatment-Resistant Schizophrenia: A FondaMental Academic Centers of Expertise for Schizophrenia (FACE-SZ) Study.

Authors:  Marion Leboyer; Ophélia Godin; Emilie Terro; Wahid Boukouaci; Ching-Lieng Lu; Myrtille Andre; Bruno Aouizerate; Fabrice Berna; Caroline Barau; Delphine Capdevielle; Julie Clauss-Kobayashi; Isabelle Chereau; Thierry D Amato; Caroline Dubertret; Julien Dubreucq; Guillaume Fond; Hakim Laouamri; Sylvain Leignier; Christophe Lancon; Pierre-Michel Llorca; Jasmina Mallet; Philippe Le Corvoisier; David Misdrahi; Christine Passerieux; Romain Rey; Baptiste Pignon; Mathieu Urbach; Andrei Szoke; Franck Schürhoff; Ryad Tamouza
Journal:  Schizophr Bull Open       Date:  2021-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.